Skip to main content
SpringerLink
Log in

ASO Author Reflections: Financial Toxicity and CRS-HIPEC—Is a Pound of Debt Worth an Ounce of Cure?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Squires MH 3rd, Staley CA, Knechtle W, Winer JH, Russell MC, Perez S, et al. Association between hospital finances, payer mix, and complications after hyperthermic intraperitoneal chemotherapy: deficiencies in the current healthcare reimbursement system and future implications. Ann Surg Oncol. 2015;22(5):1739–45. https://doi.org/10.1245/s10434-014-4025-7.

    Article  PubMed  Google Scholar 

  2. Naffouje SA, O’Donoghue C, Salti GI. Evaluation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a community setting: a cost-utility analysis of a hospital’s initial experience and reflections on the health care system. J Surg Oncol. 2016;113:544–7.

    Article  PubMed  Google Scholar 

  3. Farooq A, Merath K, Hyer JM, Paredes AZ, Tsilimigras DI, Sahara K, et al. Financial toxicity risk among adult patients undergoing cancer surgery in the United States: an analysis of the National Inpatient Sample. J Surg Oncol. 2019;120(3):397–406. https://doi.org/10.1002/jso.25605.

    Article  PubMed  Google Scholar 

  4. Ciftci Y, Radomski SN, Johnston FM, Greer JB. Predictors of financial toxicity risk among patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14577-y.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Yusuf Ciftci BS, Shannon N. Radomski MD, Fabian M. Johnston MD, MHS & Jonathan B. Greer MD

Authors
  1. Yusuf Ciftci BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shannon N. Radomski MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fabian M. Johnston MD, MHS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jonathan B. Greer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yusuf Ciftci BS.

Ethics declarations

Disclosures

SNR’s salary was supported by NCI Grant 5T32CA126607-12.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article refers to: Ciftci Y, Radomski SN, Johnston FM, Greer JB. Predictors of Financial Toxicity Risk Among Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC). Annals Surgical Oncology. 2023. https://doi.org/10.1245/s10434-023-14577-y.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ciftci, Y., Radomski, S.N., Johnston, F.M. et al. ASO Author Reflections: Financial Toxicity and CRS-HIPEC—Is a Pound of Debt Worth an Ounce of Cure?. Ann Surg Oncol 31, 2401–2402 (2024). https://doi.org/10.1245/s10434-023-14768-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14768-7

Search

Navigation